Accelerating Clinical Trials in Parkinson's

What is EJS ACT-PD?

This video provides an introduction to the EJS ACT-PD Initiative from our project co-leads: Professor Tom Foltynie (University College London) and Professor Camille Carroll (University of Plymouth).

(Subtitles available by clicking on the icon at the bottom of the video)

Latest Updates

Movement disorder congress

The EJS ACT-PD team were thrilled to attend and present at the recent MDS Congress in Madrid! The congress provided an amazing opportunity to further our understanding of the latest management strategies and research outcomes for Parkinson’s disease. Our brilliant Clinical Research Fellows presented 6 posters detailing all of our Working Groups amazing progress over the past year. You can find these on our ‘Updates and Outcomes’ page! 

EJS ACT-PD Present at the PD Frontline Webinar

Check out EJS ACT-PD presenting at the PD Frontline Webinar: ‘Trials and the Parkinson’s Community’. We presented an overview of the project, and why having people with Parkinson’s and their care partners involved in all aspects of research is so important!

The full recording is now available on YouTube via the following link:


Protocol Writing Meeting

We are delighted to announce that EJS ACT-PD held a very successful ‘Protocol Writing’ meeting in December 2022. Our Steering Group, Core Team, and patient and carer representatives thoroughly reviewed working group recommendations to make important decisions for our first draft protocol. This brilliant progress has instilled renewed excitement for the development of this revolutionary trial platform. We look forward to continuing our momentum in the New Year!

Project Overview

The EJS ACT-PD Consortium is comprised of 6 Working Groups, an overarching Steering Group and an International Advisory Group. Whilst each Working Group is focused on a specific element of the project, they work collaboratively to reach consensus on all decisions made.

Associated Partners